Medline Inc
MDLNNASDAQStock · Data from SEC EDGAR 13F · Held by 10 of 87 tracked investors
Medline Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation8
- Growth77
- Profitability31
- Quality41
- Debt25
- Stability100
- ✓The analysts' average target is 37% above the price.
- !Out of 100 USD of revenue, only 2.3 USD is left as net profit.
- !Net debt is high: at the current free cash flow it would take 11.7 years to repay.
- !The stock is expensive: you pay 83 USD for 1 USD of annual earnings.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveFor 1 USD of annual earnings you pay 83.0 USD. Based on next year's estimates 20.6 USD.
- P/E
- 83.0×
- P/S
- 1.5×
- EV/EBITDA
- 18.7×
Is the company growing?
–Too few years to compare. Last year 11.6%.
Does it make money?
WeakEarnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 5 Aug 2026 | 0.47 | 0.30 | +56.7% |
| Mar 2026 | 6 May 2026 | 0.33 | 0.29 | +13.8% |
| Dec 2025 | 25 Feb 2026 | -0.01 | 0.24 | -104.2% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart MDLN
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
10SM Stephen Mandel Lone Pine Capital | 5.06% |
JA John Armitage Egerton Capital | 4.69% |
HE Henry Ellenbogen Durable Capital Partners | 1.01% |
GS George Soros Soros Fund Management | 0.79% |
AH Andreas Halvorsen Viking Global Investors | 0.54% |
Ns Norský státní fond Norges Bank | 0.03% |
IE Israel Englander Millennium Management | 0.02% |
PT Paul Tudor Jones Tudor Investment Corp | 0.02% |
Šn Švýcarská národní banka Swiss National Bank | 0.02% |
RD Ray Dalio Bridgewater Associates | 0% |
Frequently asked questions
How much is Medline Inc (MDLN) stock?
Medline Inc shares trade at $32.38, -3.89% over the last trading day. The price is delayed.
What is the market cap of Medline Inc?
The market cap of Medline Inc is about $43.6B and its price-to-earnings ratio (P/E) is 83.
Which big investors hold Medline Inc?
According to the latest 13F filings, 10 of 87 tracked investors hold Medline Inc, for example Stephen Mandel, John Armitage, Henry Ellenbogen.
When will Medline Inc report its next results?
The next earnings report of Medline Inc is expected on 4 Nov 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.